The global market for bioprinting is projected to accelerate at a 43.9% CAGR, from $295 million in 2016 to $1.8 billion in 2021. The clinical application segment, stable in 2015 and 2016, should reach nearly $1.2 billion by 2021, or two-thirds of the total market.
Discover:
- BioPrinting's emergence as an enabling tool in research, drug discovery and development, cosmetics, and regenerative medicine.
- Bioprinting's positioning in the expanding biomimicry field – applying human versus mouse based tissue for drug screening and tissue regeneration.
- Bioprinting technologies, applications, and end-user industries and related industries.
Summary Table
GLOBAL BIOPRINTING MARKET, THROUGH 2021 ($ MILLIONS)
|
|
Application
|
2015 |
2016 |
2021 |
CAGR%
2016-2021 |
| Research and applied |
263.8 |
295 |
635.2 |
16.6 |
| Clinical |
--- |
--- |
1,188.0 |
--- |
| TOTAL |
263.8 |
295 |
1,823.2 |
43.9 |
| Source: BCC Research |
|
|
